Table 2.
Number of patients | 61 |
Age (years) | |
Median | 58 |
Range | 25-82 |
Sex | |
Male | 40 (66%) |
Female | 21 (34%) |
Eastern Cooperative Oncology Group Performance Status | |
0 | 14 (23%) |
1 | 36 (59%) |
2 | 11 (18%) |
Number of previous chemotherapy regimens | |
2 | 49 (80%) |
3 | 9 (15%) |
4 | 2 (3%) |
Concomitant use of medication | |
Antineoplastic agents (hydroxycarbamide) | 9 (15%) |
Immunostimulants (granulocyte colony-stimulating factor) | 14 (23%) |